Previously, risk reduction from treatment with endocrine therapy has been represented as a general percentage for all patients treated. Knowing that in reality each patient responds differently, Dr. Naughton stresses the importance of tailoring treatment decisions based on the individual patient situation.
For more information, visit: http://www.breastcancerindex.com
http://www.answersbeyond5.com
http://www.twitter.com/answersbyond5